Cooperative inhibition of SNARE-mediated vesicle fusion by α-synuclein monomers and oligomers
Abstract The primary hallmark of Parkinson's disease (PD) is the generation of Lewy bodies of which major component is α-synuclein (α-Syn). Because of increasing evidence of the fundamental roles of α-Syn oligomers in disease progression, α-Syn oligomers have become potential targets for therap...
Guardado en:
Autores principales: | Gyeongji Yoo, Sanghun Yeou, Jung Bae Son, Yeon-Kyun Shin, Nam Ki Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5efb5ee1fb0649f6922c3aaf4066f69e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural characteristics and membrane interactions of tandem α-synuclein oligomers
por: Chunhua Dong, et al.
Publicado: (2018) -
α-Synuclein oligomers induced by docosahexaenoic acid affect membrane integrity.
por: Chiara Fecchio, et al.
Publicado: (2013) -
The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
por: Roberta Cascella, et al.
Publicado: (2021) -
Structural basis of synaptic vesicle assembly promoted by α-synuclein
por: Giuliana Fusco, et al.
Publicado: (2016) -
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
por: Marthe H. R. Ludtmann, et al.
Publicado: (2018)